Pharmacy Benefit Managers (PBMs) 2023-2024 Review


Pharmacy Benefit Managers (PBMs) function as intermediaries between insurance providers and pharmaceutical manufacturers. PBMs create formularies, negotiate rebates with manufacturers, process claims, create pharmacy networks, review drug utilization, and more.

The rise of drug prices has increased the attention and scrutiny on PBMs, and the role they play in drug pricing both at the federal and state levels. PBMs are also encountering competition from new pharmacy players, such as Mark Cuban Cost Plus Drugs, and a number of other non-traditional market participants. Many of these companies are focused on providing transparency in pricing models.

The 2023-2024 PBM Review profiles more than 60 PBM companies. The report identifies and segments the market into Market Leaders, Mid-Market PBMs, and Non-Traditional PBMs. AMI’s report also provides a brief background on the market. Each PBM company profile includes: company background, strategy, key decision-makers, financial/investor information, products and services, and recent activities.

The report is available for $249 for a single-user license. Department and Corporate Licenses are available, please click here.